Neuraura

Neuraura Biotech Inc. is a seed-stage medical technology company based in Calgary, Canada. The company specializes in bioelectronic medicine solutions aimed at addressing chronic health conditions, with a primary focus on polycystic ovary syndrome (PCOS). Neuraura originated from the Hotchkiss Brain Institute and utilizes innovative micro-electrode technology initially developed for brain-machine interfaces. The flagship product, LoOoP, is a unique bioelectronic wearable platform designed to treat PCOS. It delivers low-frequency electrostimulation through patented microelectrodes to alleviate various symptoms associated with the condition. Complementing this device is MyLoOoP, a digital platform that provides personalized insights, curated content, and community support for users. Neuraura's advanced sensor technology offers significant improvements in size, spatial resolution, and signal quality, enhancing the effectiveness of their solutions. Co-founded by Pierre Wijdenes and Claire Dixon, Neuraura aims to improve the standard of care for individuals affected by PCOS and other chronic health disorders. The company is committed to providing evidence-backed, non-pharmaceutical options for managing these conditions, ultimately enhancing quality of life and health outcomes.

• Employees 9
• Founded 2017